Evidence map›Paper›PMID 29643119›Full record

ArticleJournal of cell science2018

Regulator of calcineurin-2 is a centriolar protein with a role in cilia length control.

Nicola L Stevenson, Dylan J M Bergen, Amadeus Xu, Emily Wyatt, Freya Henry, Janine McCaughey, Laura Vuolo, Chrissy L Hammond, David J Stephens

Open access · bronzeAbstract read
In one paragraph

Article in Journal of cell science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. A cellular atlas of calcineurin signaling.Biochimica et biophysica acta. Molecular cell research · 2023
    Review
  6. PIPCommunications biology · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. The Golgin Protein Giantin Regulates Interconnections Between Golgi Stacks.Frontiers in cell and developmental biology · 2019
    Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Nicola L StevensonCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.ORCID 0000-0001-8967-7277
Dylan J M BergenCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.ORCID 0000-0001-7808-6121
Amadeus XuCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.
Emily WyattCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.
Freya HenryCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.
Janine McCaugheyCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.
Laura VuoloCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.
Chrissy L HammondSchool of Physiology and Pharmacology, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD.ORCID 0000-0002-4935-6724
David J StephensCell Biology Laboratories, School of Biochemistry, University of Bristol, Biomedical Sciences Building, University Walk, Bristol, UK, BS8 1TD david.stephens@bristol.ac.uk.ORCID 0000-0001-5297-3240
University of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/L014181/1Biotechnology and Biological Sciences Research Council BB/N000420/1Medical Research Council MR/K018019/1Versus Arthritis 21211Versus Arthritis 21937Wellcome Trust
6 · The paper itself

Abstract

Almost every cell in the human body extends a primary cilium. Defective cilia function leads to a set of disorders known as ciliopathies, which are characterised by debilitating developmental defects that affect many tissues. Here, we report a new role for regulator of calcineurin 2 (RCAN2) in primary cilia function. It localises to centrioles and the basal body and is required to maintain normal cilia length. RCAN2 was identified as the most strongly upregulated gene from a comparative RNAseq analysis of cells in which expression of the Golgi matrix protein giantin had been abolished by gene editing. In contrast to previous work where we showed that depletion of giantin by RNAi results in defects in ciliogenesis and in cilia length control, giantin knockout cells generate normal cilia after serum withdrawal. Furthermore, giantin knockout zebrafish show increased expression of RCAN2. Importantly, suppression of RCAN2 expression in giantin knockout cells results in the same defects in the control of cilia length that are seen upon RNAi of giantin itself. Together, these data define RCAN2 as a regulator of cilia function that can compensate for the loss of giantin function.

Indexed as

AnimalsCell Cycle ProteinsCentriolesCiliaGene Knockout TechniquesGolgi Matrix ProteinsHumansMuscle ProteinsRetinal Pigment EpitheliumZebrafishCell Cycle ProteinsGolgi Matrix ProteinsmacrogolginMuscle ProteinsRCAN2 protein, humanCalcineurinCiliaGiantinGolgiRCAN2

Identifiers

PMID29643119
PMCPMC5992583
OpenAlexW2949448682

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.